-
Start Preamble
Start Printed Page 2513
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice if hereby given of a meeting of the Fogarty International Center Advisory Board.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: February 4-5, 2008.
Closed: February 4, 2008, 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications and/or proposals.
Place: National Institutes of Health, Lawton Chiles International House, Bethesda, MD 20892.
Closed: February 5, 2008, 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or proposals.
Place: National Institutes of Health, Lawton Chiles International House, Bethesda, MD 20892.
Open: February 5, 2008, 10:30 a.m. to 3:30 p.m.
Agenda: Advisory Board Topics will include discussion of the five year strategic plan, as well as discussion on research challenges related to the rising prevalence of non-communicable diseases in low- and middle- income countries. Discussion will feature a recent Delphic analysis to identify key scientific questions and pursuits in non-communicable disease prevention and treatment in these regions.
Place: National Institutes of Health, Lawton Chiles International House, Bethesda, MD 20892.
Contact Person: Robert Eiss, Public Health Advisor, Fogarty International Center, National Institutes of Health, 31 Center Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415, EISSR@MAIL.NIH.GOV.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home page: http://www.nih.gov/fic/about/advisory.html, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority International Research Training Grant in the Biomedical and Behavioral Sciences; 93.154, Special International Postdoctoral Research Program in Acquired Immunodeficiency Syndrome; 93.168, International Cooperative Biodiversity Groups Program; 93.934, Fogarty International Research Collaboration Award; 93.989, Senior International Fellowship Awards Program, National Institutes of Health, HHS)
Start SignatureDated: January 8, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-99 Filed 1-14-08; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 2/4/2008
- Published:
- 01/15/2008
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 08-99
- Dates:
- February 4-5, 2008.
- Pages:
- 2513-2513 (1 pages)
- PDF File:
- 08-99.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute